Recent

• ‘Right To Try Laws’ and Legal Access to Psilocybin Therapy with Dr. Jonathan Fields
• Compass Pathways Phase 2 Psilocybin Results far from Spectacular
• Math Over Myth: Compass and Revive Release Phase 3 Updates but Stocks Drop
• Math Over Myth: Spotlight on Psychedelic Stocks ATAI & COMPASS
• Psychedelic Stocks: ARK Invest and the Reverse Midas Touch
• Compass Pathways Sued for Stealing Trade Secrets
• Three Phase 3 Clinical Trials that Could Legalize Psychedelics
• A Big Week for Psychedelic Stocks: 2 CEOs Step Down, MDMA Patents and a Phase 3 Trial
• Compass Pathways Appoints a New CEO
• Compass Pathways Psilocybin Patent Upheld